Clinical Trial: Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma

U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06405321) titled 'Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma' on May 4.

Brief Summary: This multicenter retrospective study which included patients with hepatocellular carcinoma (HCC) who received conversion or neoadjuvant therapy to explore the best treatment options and the best benefit group.

Study Type: Observational

Condition: Hepatocellular Carcinoma

Intervention: Drug: Conversion or neoadjuvant therapy.

Patients with hepatocellular carcinoma received conversion or neoadjuvant therapy.

Recruitment Status: Recruiting

Published by HT Digital Content Services with permission from Health Daily Digest....